A U.S. federal judge in Texas denied attempts by the U.S. Food and Drug Administration to conceal data on Pfizer’s COVID-19 vaccine.
An alleged plan by Johnson & Johnson to spin off a company solely responsible for J&J’s talc-based products in order to mitigate lawsuit damages is still on the table following a ruling by a federal judge.
A federal judge ruled that a decade’s worth of unpublished clinical trial data from drug companies, universities and other agencies involved must be made public.
